Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men

BACKGROUND: HIV-infected men are at increased risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer caused by vaccine types. METHODS: AIDS Malignancy Consortium Protocol 052 is a single-arm, open-label, multi-center clinical trial to assess the safety and immunogenicit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wilkin, Timothy, Lee, Jeannette Y., Lensing, Shelly Y., Stier, Elizabeth A., Goldstone, Stephen E., Berry, J. Michael, Jay, Naomi, Aboulafia, David, Cohn, David L., Einstein, Mark H., Saah, Alfred, Mitsuyasu, Ronald T., Palefsky, Joel M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3118428/
https://ncbi.nlm.nih.gov/pubmed/20812850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/656320
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados